SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-152627
Filing Date
2024-06-03
Accepted
2024-06-03 10:32:05
Documents
22
Period of Report
2024-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820863d8k.htm   iXBRL 8-K 32116
2 EX-5.1 d820863dex51.htm EX-5.1 15941
3 EX-5.2 d820863dex52.htm EX-5.2 8892
4 EX-10.1 d820863dex101.htm EX-10.1 208501
5 EX-10.2 d820863dex102.htm EX-10.2 85007
6 EX-10.3 d820863dex103.htm EX-10.3 83985
7 EX-10.4 d820863dex104.htm EX-10.4 78595
11 GRAPHIC g820863snap1.jpg GRAPHIC 2646
12 GRAPHIC g820863snap2.jpg GRAPHIC 1817
13 GRAPHIC g820863snap4.jpg GRAPHIC 3589
  Complete submission text file 0001193125-24-152627.txt   786171

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA apto-20240530.xsd EX-101.SCH 2514
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apto-20240530_lab.xml EX-101.LAB 17912
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apto-20240530_pre.xml EX-101.PRE 11225
26 EXTRACTED XBRL INSTANCE DOCUMENT d820863d8k_htm.xml XML 3748
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 241012433
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)